Zpráva o průběhu neintervenční observační studie Ponderosa Annual Report 2023

Title in English Report on the progress of the non-interventional observational study Ponderosa Annual Report 2023
Authors

DEMLOVÁ Regina MATYŠKOVÁ Šárka

Year of publication 2023
MU Faculty or unit

Faculty of Medicine

Web
Description This study aims at giving a picture of real-life treatment with ponatinib in CML patients. The study will assess the incidence of adverse events (AEs) and response to treatment. The annual report of the observational study contains data about recruitment of subjects in individual clinical trial centers, the incidence of serious adverse reactions and their reporting, identified protocol violations and information on newly identified findings on the investigational medicinal product in relation to its safety and efficacy.

You are running an old browser version. We recommend updating your browser to its latest version.

More info